BCHE and early-onset autosomal dominant Alzheimer disease: In the first part of the review, the most important therapeutic targets in Alzheimer’s disease, such as the inhibition of cholinesterase activity, the inhibition of amyloid fibrils production, the inhibition of monoamine oxidases, pancreatic lipase, tyrosinase, inflammatory effects and antioxidant activity, will be discussed.